금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
World Bank warns of risks of global slowdown, renewed inflation
The World Bank warned that the global economy is only "a few months" away from a worst-case scenario...
US – Fed preview: A divided hold
The first month after Kevin Warsh's debut at the FOMC's June meeting has brought mixed signals on th...
US-Iran conflict intensifies
The Yen retreated against the USD, reaching new 40-year lows and JPY traders sounded the alarm for a...
2 Reasons to Sell MC and 1 Stock to Buy Instead
Over the last six months, Moelis’s shares have sunk to $65.46, producing a disappointing 8.5% loss - a stark contrast to the S&P 500’s 6.2% gain. This was partly driven by its softer quarterly results ...
Update: US Equity Indexes Lower in Final Leg of Trading as Technology Slides With Crude Oil
(Updates with index/price moves data, and political news from the first paragraph.) US stocks tra
Dow, Nasdaq Turn Lower to Wrap Wild Week
Sideways trading for stocks continued heading into the final hour of the week. The Dow was down 40 points, or 0.1%. It would be rising if not for steep drops in Goldman Sachs and Caterpillar, which ar ...
Central Garden & Pet (CENT): Buy, Sell, or Hold Post Q1 Earnings?
Central Garden & Pet’s 36.1% return over the past six months has outpaced the S&P 500 by 29.9%, and its stock price has climbed to $44.51 per share. This was partly due to its solid quarterly results, ...
Ardelyx stock decline attributed to setback in Xphozah appeal
S&P 500 Index divergence: Equal-weight climbs while cap-weight melts
Horace Mann Educators (HMN): Buy, Sell, or Hold Post Q1 Earnings?
Horace Mann Educators trades at $50.71 per share and has stayed right on track with the overall market, gaining 9% over the last six months. At the same time, the S&P 500 has returned 6.2%.
Tech Took a Header. The Rest of the Market Marched On.
The market’s breadth—the number of advancing stocks versus declining ones—has still been positive, even on days when tech is a mess.
Healthcare stocks have become a haven for investors ditching tech
Shares of AbbVie, Eli Lilly and Johnson & Johnson were on track to hit all-time highs Friday, in the latest signal that investor appetite for the biopharmaceutical sector is back.
FuelCell Energy surges as Jefferies upgrades to Buy on data center power upside
Women's apparel brand Reformation files for an IPO